foxo4-dri news Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell FOXO4-DRI Peptide | Senolytic &

Administered intramuscularly (IM) or intravenously (IV) under medical supervision

It can only convert known inputs, such as a prescribed amount and a known concentration

Topical application delivers GHK-CU directly to skin tissue

In some embodiments, the amount of thickening agent (e.g., a gelling agent) in any formulation described herein is about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09%, about 0.1%, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 5%, about 10%, or about 15% of the total weight of the formulation